论文信息 - Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. - 字舞流文

Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.

G. Stone | M. York | A. Lincoff | R. Mehran | D. Cohen | D. Pinto | D. Cox | E. Ohman | M. Reynolds | Duane S Pinto | R. Berezin | B. Mclaurin | C. Shi | E. Dunn | J. Walczak | B. McLaurin | Joshua Walczak